Woodard & Co. Asset Management Group Inc. ADV bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 4,967 shares of the healthcare conglomerate's stock, valued at approximately $1,550,000.
Several other large investors have also made changes to their positions in the company. Novare Capital Management LLC grew its holdings in shares of UnitedHealth Group by 15.5% in the 2nd quarter. Novare Capital Management LLC now owns 53,507 shares of the healthcare conglomerate's stock worth $16,693,000 after purchasing an additional 7,174 shares during the last quarter. Arnhold LLC grew its holdings in shares of UnitedHealth Group by 52.3% in the 2nd quarter. Arnhold LLC now owns 73,213 shares of the healthcare conglomerate's stock worth $22,840,000 after purchasing an additional 25,150 shares during the last quarter. William Blair Investment Management LLC grew its holdings in UnitedHealth Group by 9.5% during the 2nd quarter. William Blair Investment Management LLC now owns 684,141 shares of the healthcare conglomerate's stock worth $213,431,000 after acquiring an additional 59,120 shares during the last quarter. Koshinski Asset Management Inc. grew its holdings in UnitedHealth Group by 16.7% during the 2nd quarter. Koshinski Asset Management Inc. now owns 10,825 shares of the healthcare conglomerate's stock worth $3,377,000 after acquiring an additional 1,546 shares during the last quarter. Finally, Citizens Business Bank grew its holdings in UnitedHealth Group by 0.9% during the 2nd quarter. Citizens Business Bank now owns 8,368 shares of the healthcare conglomerate's stock worth $2,611,000 after acquiring an additional 75 shares during the last quarter. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
Shares of NYSE:UNH opened at $356.53 on Friday. The company has a market capitalization of $322.90 billion, a price-to-earnings ratio of 15.45, a P/E/G ratio of 2.31 and a beta of 0.47. The firm's 50 day simple moving average is $329.38 and its 200 day simple moving average is $344.86. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
Analyst Ratings Changes
UNH has been the topic of a number of research analyst reports. KeyCorp increased their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a report on Wednesday, October 8th. Robert W. Baird reissued an "underperform" rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Morgan Stanley upped their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a research report on Friday, September 12th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Mizuho upped their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an "outperform" rating in a research report on Thursday, October 9th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $385.13.
Read Our Latest Stock Analysis on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.